Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-22-049215

Chief Technology Officer acquired 2,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hudkins Robert L. Chief Technology Officer 2022-03-15 Grant or award +2,408 $8.53 $20,529 272,536 D
Derivatives
Hudkins Robert L. Chief Technology Officer 2022-09-06 Grant or award · Stock Option (Right to Buy) +105,000 105,000 D
Loading xslF345X03/doc4.xml…